Drug factory · FDA FEI 3007933377
Privates Untersuchungsinstitut Heppeler GmbH
Marie-Curie-Str. 7, Lörrach, Germany
Problems found, fixed voluntarily at FDA's last inspection, Apr 11, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
4 drug inspections on record since 2009: 3 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Maribavir | Tests it | Takeda Pharmaceuticals America, Inc. | 64764-800 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Apr 11, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 4, 2016 | No problems found | Drug Quality Assurance | — |
| Jan 23, 2014 | No problems found | Drug Quality Assurance | — |
| Dec 4, 2009 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.